According to the American Cancer Society, almost 1.9 million new cancer cases are expected to be diagnosed in 2021. They also estimate that in the United States, 40 out of 100 people will develop cancer during their lifetime.
While cancer can not be prevented, advancements in screening methods and measures of self-awareness can help to detect cancer in its earliest stages. This week, Dr. Scot Ackerman joined WJXT to discuss two Olympians who have previously been diagnosed with cancer, Kevin McDowell and Chaunte Lowe, and the impact that their self-awareness and advanced screening played in making full recoveries.
Kevin McDowell and Shaunte Lowe
Kevin McDowell is a seven time World Triathlon Cup medalist, 2017 USA Triathlon Elite National Champion, and now 2021 Olympian, who was diagnosed with Hodgkin’s Lymphoma in 2011 at the age of 18. After receiving treatment and making a full recovery, he went on to place 6th in the 2021 Olympics, which is the best placement by an American male in the Olympic history of this sport.
Chaunte Lowe is a four time high jump Olympian and two time World Championship medalist, who was diagnosed with triple-negative invasive ductal carcinoma in 2019 at the age of 36. She continued her training during her first rounds of treatment, and after making a full recovery she continued her training for the 2021 Olympic trials.
Advanced Treatment, Screening and Survivorship
Over the past several decades, studies have shown that the five year relative survival rate for cancer patients has increased by about 30%. This can be attributed to advancements in technology and personalized treatment, as well as early detection. One of the most important recovery factors is your overall health. Both of these athletes’ overall health positively influenced their personalized treatments and outcomes.
To view the full interview with Dr. Scot Ackerman and WJXT, click here.
To learn more about the treatment options offered at Ackerman Cancer Center, click here.